Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Apr;57(4):1051-8.
doi: 10.1172/JCI108347.

Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes

Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes

R E Rocklin. J Clin Invest. 1976 Apr.

Abstract

Histamine, one of the mediators involved in the IgE-mediated reaction, was demonstrated to influence in vivo and in vitro components of cellular-immune reactions in orthochlorbenzoyl-bovine gamma globulin-immune guinea pigs. 10(-3) M histamine reduced by half the size of a delayed hypersensitivity skin test at 24 h. Inhibition of skin reactivity by histamine could be partially reversed by H-1 receptor antagonists such as chlorpheniramine and completely prevented by H-2 receptor antagonists such as burimamide. The histamine suppression of cutaneous delayed hypersensitivity could be accounted for in part by its inhibitory effect on certain lymphocyte responses including antigen-induced migration inhibitory factor (MIF) production and proliferation. At concentrations of 10(-3)-10(-5) M histamine reversibly inhibited MIF production and its action could be blocked by H-2 antagonists but not H-1 antagonists. Thus, lymphocytes bearing H-2 receptors modulate MIF production and probably lymphocyte proliferation as well. Histamine did not interfere with the macrophage response to preformed MIF. These studies indicate that immediate hypersensitivity reactions involving histamine release might influence the subsequent expression of cellular-immune reactions.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1971 Sep 1;134(3 Pt 1):741-50 - PubMed
    1. Science. 1971 Aug 20;173(3998):743-5 - PubMed
    1. J Immunol. 1973 Aug;111(2):389-94 - PubMed
    1. J Clin Invest. 1974 Mar;53(3):735-44 - PubMed
    1. Science. 1974 Apr 5;184(4132):19-28 - PubMed

Publication types

MeSH terms